期刊文献+

小鼠CD25分子胞外段的真核表达载体的构建

Construction and identification of eukaryotic expression vector of mouse CD25 extracellular domain
下载PDF
导出
摘要 目的构建小鼠CD25分子胞外段的真核表达载体,并在CHO细胞中进行表达。方法从前期构建的原核表达载体PET-32a-CD25胞外段上酶切下CD25胞外段;将其亚克隆入真核表达载体pcDNA3.1,并进行酶切及测序鉴定;用Lipofectamine 2000将pcDNA3.1-CD25胞外段转染中国仓鼠卵巢细胞(Chinese Hamster Ovary,CHO)进行表达,并用ELISA法对表达产物进行测定。结果酶切、测序验证成功构建真核表达载体pcDNA3.1-CD25e,并在CHO细胞中有效表达CD25e蛋白。结论成功构建小鼠CD25胞外段的真核表达载体,可在CHO细胞中表达,并具有良好的免疫反应性,为后续实验提供了前期基础。 Objective To construct a eukaryotic expression vector of mouse CD25 extracellular domain and to express it in CHO. Methods The prokaryotie expression vector PET-32a-CD25e was digested with EcoR I and Hind III. The target sequence was subeloned into eukaryotic expression vector pcDNA3.1/Myc-his- (-). The recombinant plasmid was identified through enzyme cleaving and sequencing before expression. The recombinant plasmids were transferred into ClIO by Lipofectamine 2000. The concentration of target molecule in supematant was detected by ELISA assay. Results The recombinant plasmid pcDNA3.1-CD25 extracellular domain gene was identified by sequencing and could express CD25e protein in CHO cells. Conclusions The mouse CD25 extracellular domain has been successfully expressed in eukaryotic cells, which provided the foundation for further relative studies.
出处 《遵义医学院学报》 2010年第4期316-318,共3页 Journal of Zunyi Medical University
基金 国家自然科学基金(30901318) 贵州省省长基金项目(09-124)
关键词 CD25胞外段 真核表达 T细胞疫苗 CD25 extracellular domain eukaryotic expression T cell vaccine
  • 相关文献

参考文献11

  • 1Hellings N, Stinissen P. Tovaxin, radiation-attenuated, patient-specific T-cells for the therapeutic vaccination of multiple sclerosis[J]. Curr Opin Investig Drugs, 2008, 9(5):534-540.
  • 2Vandenbark AA, Abulafia-Lapid R. Autologous T-cell vaccination for multiple sclerosis: a perspective on progress [J]. BioDrugs, 2008, 22(4):265-273.
  • 3Abulafia-Lapid R, Mayan S, Bentwich Z, et al. T-cell vaccination against anti-CD4 autoimmunity in HIV-1 subtypes B and C-infected patients--an extended open trial [J]. Vaccine, 2005, 23(17-18):2149-2153.
  • 4Volovitz I, Marmor Y, Mor F, et al. T cell vaccination induces the elimination of EAE effector T cells: analysis using GFP- transduced, encephalitogenic T cells[J]. J Autoimmun, 2010, 35(2):135-44.
  • 5Quintana FJ, Mimran A, Carmi P, Mor F, Cohen IR. HSP60 as a target of anti-ergotypic regulatory T cells[J]. PLoS One, 2008,3(12):e4026.
  • 6Mimran A, Mot F, Carmi P, et al. DNA vaccination with CD25 protects rats from adjuvant arthritis and induces an antiergotypic response[J]. J Clin Invest. 2004, 113(6):924-932.
  • 7Xu L, Zhang F, Xu W, et al. Specific antibodies induced by DNA vaccination with extracellular domain of CD25 gene protect against ConA-induced autoimmune hepatitis[J]. Clin Immunol, 2009, 132(3):412-419.
  • 8徐林,张凤,周涯,罗军敏,覃明.小鼠CD25分子胞外段的原核表达载体的构建及表达鉴定[J].第三军医大学学报,2010,32(3):278-281. 被引量:2
  • 9徐林,张凤,周涯,罗军敏,覃明,姚新生.CD25分子胞外段基因免疫应答中B淋巴细胞的变化及意义[J].西安交通大学学报(医学版),2010,31(6):659-663. 被引量:1
  • 10Loetus B, Nwesom B, Montgomery M, et al. Autologous attenuated T-cell vaccine (Tovaxin) dose escalation in multiple sclerosis relapsing-remitting and secondary progressive patients nonresponsive to approved immunomodulatory therapies[J]. Clin Immunol, 2009,131(2):202-15.

二级参考文献18

  • 1Qi Cao,Li Wang,Fang Du,Huiming Sheng,Yan Zhang,Juanjuan Wu,Baihua Shen,TianweiShen,Jingwu Zhang,Dangsheng Li,Ningli Li.Downregulation of CD4+CD25+ regulatory T cells may underlie enhanced Th1 immunity caused by immunization with activated autologous T cells[J].Cell Research,2007,17(7):627-637. 被引量:5
  • 2Hellings N, Stinissen P. Tovaxin, radiation-attenuated, patient-specific T- cells for the therapeutic vaccination of multiple sclerosis[ J ]. Curr Opin Investig Drugs, 2008, 9(5) : 534 -540.
  • 3Vandenbark A A, Abulafia-Lapid R. Autologous T-cell vaccination for multiple sclerosis: a perspective on progress[ J ]. BioDrugs, 2008, 22 (4) : 265 -273.
  • 4Abulafia-Lapid R, Mayan S, Bentwich Z, et al. T-cell vaccination against anti-CD4 autoimmunity in HIV-1 subtypes B and C-infected patients-an extended open trial [J]. Vaccine, 2005, 23 ( 17 - 18 ) : 2149 -2153.
  • 5Wang J, Jiang S, Shi H, et al. Prolongation of corneal xenotransplant survival by T-cell vaccination-induced T-regulatory cells [ J ]. Xenotransplantation, 2008, 15 (3) : 164 - 173.
  • 6Quintana F J, Cohen I R. Anti-ergotypic immunoregulation[J]. Seand J Immunol, 2006, 64(3) : 205 -210.
  • 7Yang Y, Ratts R B, Hussain R Z, et al. CD28 : B7 interaction is necessary for the protective effect of T cell vaccination in EAE[J]. Eur J lmmunol, 2007, 37 (7) : 2032 - 2042.
  • 8Cohen I R, Quintana F J, Mimran A. Tregs in T cell vaccination : exploring the regulation of regulation[ J]. J Clin Invest, 2004, 114(9) : 1227 - 1232.
  • 9Kumar V. Homeostatic control of immunity by TCR peptide-specific Tregs[J]. J Clin Invest, 2004, 114(9) : 1222 -1226.
  • 10Herkel J, Brunner S, Meyer-zum-Buschenfelde K H, et al. Humoral mechanisms in T cell vaccination: induction and functional characterization of anti-lymphocytic autoantibodies [ J]. J Autoimmun, 1997, 10 (2) : 137 - 146.

共引文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部